Skip to main content

Table 4 Maternal measurements and data collection time points

From: The University of Zimbabwe College of Health Sciences (UZ-CHS) BIRTH COHORT study: rationale, design and methods

Variables

Research visit (in weeks)

Pregnancy

Delivery

1

6

10

14

24

36

48

72

96

A. Maternal life style

1. Current alcohol use

✓

  

✓

  

✓

   

✓

2. Smoking

           

3. Living under same roof with spouse/partner

✓

  

✓

  

✓

   

✓

4. Current marital/ domestic violence

✓

  

✓

  

✓

   

✓

5. Physical activity

✓

     

✓

   

✓

B. Household factors

1. Household numbers & composition

✓

  

✓

  

✓

   

✓

2. Number of rooms available

✓

  

✓

  

✓

   

✓

3. Main source of drinking water

✓

  

✓

  

✓

   

✓

4. Main source of energy for cooking (household pollution)

✓

  

✓

  

✓

   

✓

5. Main place for cooking

✓

  

✓

  

✓

   

✓

6. Sleeping arrangements

✓

  

✓

  

✓

   

✓

Water and sanitation

✓

  

✓

  

✓

   

✓

7. Presents of family diarrhoeal diseases

✓

  

✓

  

✓

   

✓

C. Nutritional factors

1. Maternal number of meal a day

✓

  

✓

  

✓

   

✓

2. Household meals eaten per day

✓

  

✓

  

✓

   

✓

3. Food frequency questionnaire

✓

  

✓

  

✓

   

✓

4. Food security tool

✓

  

✓

  

✓

   

✓

5. Perceived food allergens/ adverse reactions

✓

  

✓

  

✓

   

✓

6. 24 h food recall

✓

     

✓

   

✓

7. Craved foods

✓

          

8. Any disorder related to food mastication and/ or retention

✓

  

✓

  

✓

   

✓

9. Bristol stool chart

✓

         

✓

D. General health

1. Use of condom and sexual behaviour

✓

  

✓

  

✓

   

✓

2. Past and current methods of contraception used

✓

✓

 

✓

  

✓

   

✓

3. 7Health seeking behaviour

✓

  

✓

  

✓

   

✓

4. Tb symptoms checklist for active Tb

✓

✓

 

✓

  

✓

   

✓

5. History of Tb disease and treatment

✓

     

✓

   

✓

6. Current and past other opportunistic infections

✓

  

✓

  

✓

   

✓

7. Past and current symptoms of sexually transmitted infections

✓

✓

 

✓

  

✓

   

✓

8. Past or current hypertension

✓

✓

 

✓

  

✓

   

✓

9. Past or current stress

✓

✓

 

✓

  

✓

   

✓

10. Baby blues assessment tool

 

✓

         

11. Depression

✓

✓

    

✓

   

✓

12. Hospitalisation in the past 3 months

✓

  

✓

  

✓

   

✓

13. Sick clinic visits during index pregnancy

✓

          

14. Vaccinations during index pregnancy

✓

          

15. Timing of antenatal booking, number of subsequent visits

✓

          

16. Knowledge of pregnancy disorders that warrant immediate hospitalization

✓

          

17. Concurrent medication and supplements

✓

✓

 

✓

  

✓

   

✓

18. Concurrent herbal and traditional medication

✓

✓

 

✓

  

✓

   

✓

19. Use of sexual enhancing herbs/ substances

✓

     

✓

   

✓

20. History of routine dental or pap smear checks

✓

     

✓

   

✓

21. Anthropometric measurements (BMI, MUAC))

✓

✓

✓

✓

✓

✓

✓

   

✓

22. Systolic and diastolic BP and pulse measurements

✓

✓

✓

✓

✓

✓

✓

   

✓

23. General physical examination (e.g. oedema)

✓

✓

✓

✓

✓

✓

✓

   

✓

24. Last date of menstruation

           

E. HIV-infected only: ART use, duration, disclosure & adherence

1. ART use regimen, duration, switching of regimens

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

2. Presence of adequate supplies

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

3. ART side effects

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

4. Non-adherence issues

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

5. Disclosure of HIV status

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

6. Stigma experience

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

7. WHO clinical staging for the HIV-infected

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

F. Clinical data collected at delivery

1. Mode of delivery

 

✓

         

2. Duration of labour

 

✓

         

3. Live and stillbirths

           

4. Term/ preterm delivery

           

5. Pregnancy outcome

 

✓

         

6. Length of stay in hospital/ clinic after delivery

 

✓

         

7. Obstetric related complications

           

8. Time of previous ART intake for HIV-infected mothers

 

✓

         

G. Biological specimen collection in the 3rd trimester

1. Stool

✓

          

i) Intestinal helminths testing

           

ii) Microbiome profiles (sub-studies)

           

2. Urine

i) Urinalysis and storage microbiome

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

3. Blood

           

i) Serology, molecular genetics, HIV, CMV, HBV, syphilis

✓

         

✓

ii) TB QuantiFERON gold (sub-study)

✓

  

✓

       

iii) Full blood counts

✓

         

✓

iv) Infant vaccine titres

✓

         

✓

v) Biochemistry

✓

          

a. Dyslipidaemia

✓

         

✓

b. Kidney function tests

✓

         

✓

c. Liver function tests

✓

         

✓

i) Vitamin D

✓

         

✓

ii) HbA1c, random glucose

✓

          

iii) Cytokine profiles

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

iv) CD4 counts

✓

         

✓

v) HIV RNA load

✓

   

✓

     

✓

vi) CMV DNA load

✓

         

✓

vii) HBV DNA load

           

viii) Host genetic susceptibility

          

✓

ix) Immunometabolomics

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

H. Delivery bio-specimens

1. Placental pathology in latent Tb (sub-study), microbiome

 

✓

         

2. Amniotic-fluid co-infections, alcohol levels, microbiome

 

✓

         

3. Breast milk (lipid profiles and microbiome, CMV viral load), microbiome

 

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

I. Spouse/ intimate partner factors (as reported by mothers)

1. Age

✓

          

2. Occupation

✓

         

✓

3. Previous marital status

✓

          

4. HIV status, ART usage

✓

         

✓

5. Participation in pregnancy, ante

✓

         

✓

6. Participation in child care

✓

  

✓

      

✓

  1. ART antiretroviral therapy, BMI body mass index, CD4 cluster of differentiation-4, CMV cytomegalovirus, EPI The expanded program of immunisation, MUAC mid upper arm circumference, HbA1c glycated haemoglobin, HBV hepatitis B virus, HCV hepatitis C virus, HLA human leukocyte antigen, HIV human immunodeficiency virus, KIR killer cell immunoglobulin-like receptor, SGA small for gestational age, TB tuberculosis, WHO world health organisation